JADE1 and nonpapillary renal cell carcinoma: Clinically, Jade-1 expression has been associated with RCC irrespective of VHL [33], together suggesting an important role for Jade-1 in ccRCC development, and RCC patients with lower levels of Jade-1 had significantly shorter survival [34].